These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17911471)

  • 1. Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
    Fuchs S; Feferman T; Zhu KY; Meidler R; Margalit R; Wang N; Laub O; Souroujon MC
    Ann N Y Acad Sci; 2007 Sep; 1110():550-8. PubMed ID: 17911471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
    Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Brenner T; Laub O; Souroujon MC
    Ann N Y Acad Sci; 2008; 1132():244-8. PubMed ID: 18567875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
    Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Wang N; Zhu KY; Brenner T; Laub O; Souroujon MC
    J Neuroimmunol; 2008 Feb; 194(1-2):89-96. PubMed ID: 18178258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
    Fuchs S; Feferman T; Meidler R; Brenner T; Laub O; Souroujon MC
    Isr Med Assoc J; 2008 Jan; 10(1):58-60. PubMed ID: 18300576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
    Zhu KY; Feferman T; Maiti PK; Souroujon MC; Fuchs S
    J Neuroimmunol; 2006 Jul; 176(1-2):187-97. PubMed ID: 16730380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modulation of experimental myasthenia gravis by IVIg].
    Berrih-Aknin S; Aissaoui A; Yamamoto M; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S25-9. PubMed ID: 10896985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH; Barchan D; Maiti PK; Raveh L; Souroujon MC; Fuchs S
    FASEB J; 2001 Oct; 15(12):2140-8. PubMed ID: 11641240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.
    Thiruppathi M; Sheng JR; Li L; Prabhakar BS; Meriggioli MN
    J Autoimmun; 2014 Aug; 52():64-73. PubMed ID: 24388113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC; Brenner T; Fuchs S
    Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
    Souroujon MC; Aricha R; Feferman T; Mizrachi K; Reuveni D; Fuchs S
    Ann N Y Acad Sci; 2012 Dec; 1274():120-6. PubMed ID: 23252906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
    Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
    Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
    Lavrnić DB; Stojanović V; Marinković Z; Pavlović S; Vidaković A; Apostolski S
    Srp Arh Celok Lek; 1995; 123(5-6):146-8. PubMed ID: 17974459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis.
    Li J; Tüzün E; Wu XR; Qi HB; Allman W; Saini SS; Christadoss P
    J Neuroimmunol; 2008 Feb; 194(1-2):44-53. PubMed ID: 18207575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.